International Overdose Awareness Day marks 25 years, spotlighting fragile declines in deaths and urging naloxone access, harm reduction funding, and stigma-free care.
|Podcasts|October 20, 2020
Navigating Addiction Treatment in the Face of Difficulties
Author(s)John Calvin Chatlos, MD
How can clinicians help patients struggling with addiction, especially during this time when uncovering past traumas might feel impractical?
Advertisement
PSYCHPEARLS PODCAST
How can clinicians help patients struggling with addiction, especially during this time when uncovering past traumas might feel impractical?
Psychiatric Times interviews child and adolescent and addiction psychiatrist, John Calvin Chatlos, MD. Dr Chatlos is affiliated with Rutgers-Robert Wood Johnson Medical School, in New Brunswick, NJ, and medical director of the Wei Ji Point Ambulatory Withdrawal Management program and the Specialized Addiction Treatment Services outpatient program.
Advertisement
Related to this article
BioVie completes treatment visits in a phase 2 long COVID trial of bezisterim targeting brain fog and fatigue, with topline results expected September 2026.
Axsome launches SUMMIT phase 3 testing AXS-05 to help adults quit smoking, comparing it with bupropion and placebo over 12 weeks.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Vol 43, Issue 9 - Interactive
2
FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval
3
Debunking the Top 10 Misleading Claims About Antidepressants
4
What Low Doses of VRAYLAR® (Cariprazine) May Mean for Clinical Practice
5